Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. News
  7. Summary
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ROCHE HOLDINGS AG : JP Morgan gives a Neutral rating

09/17/2021 | 07:16am EDT

In his latest research note, analyst Richard Vosser confirms his recommendation. The broker JP Morgan is keeping its Neutral rating. The target price is unchanged at CHF 360.


ę MarketScreener with dpa-AFX Analyser 2021
All news about ROCHE HOLDING AG
12:31pROCHE : FDA Approves Genentech's Tecentriq as Adjuvant Treatment for Certain People With E..
BU
12:30pROCHE : US FDA approves Roche's Tecentriq as adjuvant treatment for certain people with ea..
AQ
12:30pPRESS RELEASE : US FDA approves Roche's Tecentriq -2-
DJ
12:30pPRESS RELEASE : US FDA approves Roche's Tecentriq as adjuvant treatment for certain people..
DJ
11:05aGENENTECH : FDA Approves Tecentriq as Adjuvant Treatment for Certain Lung Cancer Patients
DJ
01:43aROCHE : Joins PathAI to Develop AI-Based Image Analysis Workflow for Pathologists
MT
01:00aROCHE : announces PathAI collaboration for artificial intelligence-based digital pathology..
AQ
01:00aPRESS RELEASE : Roche announces PathAI collaboration for artificial intelligence-based dig..
DJ
10/14ROCHE : U.S. FDA advisers to review Merck's oral COVID-19 drug next month
RE
10/14ROCHE : FDA accepts REGEN-COV (casirivimab and imdevimab) for priority review for treatmen..
PU
More news
Analyst Recommendations on ROCHE HOLDING AG
More recommendations
Financials
Sales 2021 61 787 M 66 909 M 66 909 M
Net income 2021 14 572 M 15 780 M 15 780 M
Net cash 2021 4 469 M 4 840 M 4 840 M
P/E ratio 2021 20,9x
Yield 2021 2,60%
Capitalization 313 B 339 B 339 B
EV / Sales 2021 5,00x
EV / Sales 2022 4,86x
Nbr of Employees 101 465
Free-Float 83,5%
Chart ROCHE HOLDING AG
Duration : Period :
Roche Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROCHE HOLDING AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 360,25 CHF
Average target price 382,53 CHF
Spread / Average Target 6,19%
EPS Revisions
Managers and Directors
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Technology Officer
Christoph Franz Chairman
Urs Jaisli Chief Compliance Officer
AndrÚ S. Hoffmann Vice Chairman
Sector and Competitors
1st jan.Capi. (M$)
ROCHE HOLDING AG15.58%336 383
JOHNSON & JOHNSON2.49%421 487
PFIZER, INC.13.20%233 631
NOVO NORDISK A/S51.58%230 493
ELI LILLY AND COMPANY40.89%214 579
MERCK & CO., INC.-4.24%198 283